Eli Lilly has officially reached a market capitalization of $1 trillion, marking a significant milestone as the first publicly traded company in the healthcare sector to...
Novo Nordisk has announced a significant reduction in the price of its weight-loss drug Wegovy, cutting the monthly cost for uninsured patients to $349, down from...
The Trump administration is currently in negotiations with pharmaceutical companies Novo Nordisk and Eli Lilly to potentially lower prices for their popular weight loss medications, including...
The US Food and Drug Administration (FDA) has granted clearance to a new blood test designed to assist in assessing the likelihood of Alzheimer’s disease in...
A federal judge in Delaware has dismissed a lawsuit filed by Eli Lilly, the manufacturer of popular weight loss drugs Mounjaro and Zepbound, against Strive Pharmacy,...
A federal judge in Delaware has dismissed a lawsuit filed by Eli Lilly, the manufacturer of the popular weight loss medications Mounjaro and Zepbound, against Strive...
Eli Lilly has unveiled a new innovation hub, Gateway Labs, in San Diego, aimed at nurturing biotechnology startups and enhancing its own pharmaceutical pipeline. The launch...
Eli Lilly has reported promising results from its latest Phase III trial of an experimental oral medication designed to combat obesity. The drug, known as orforglipron,...
Eli Lilly’s recent data indicates that its GLP-1 obesity medication is less effective than a similar product from Novo Nordisk. The company reported that patients lost...
